Jan 23, 2026 12:56PM
Mar 6, 2023 09:00PM
Feb 19, 2023 09:00PM
Feb 8, 2023 09:00PM
Feb 3, 2023 09:00PM
Aug 9, 2022 08:04AM
Aug 9, 2022 08:00AM Fate Therapeutics Announces Preclinical Publication Highlighting Derivation of CD8αβ T Cells from TCR-CAR+ Induced Pluripotent Stem Cells
Aug 9, 2022 08:00AM
Jan 5, 2021 09:30AM
Jan 4, 2021 06:02PM
Dec 7, 2020 09:26AM
May 5, 2020 05:43PM
May 5, 2020 04:01PM
May 5, 2020 04:01PM Fate Therapeutics Announces Changes to its Board of Directors
Dec 9, 2019 09:29AM
Aug 8, 2019 07:18AM
Jan 18, 2018 09:20AM
Dec 11, 2017 09:17AM
Sep 14, 2017 08:00AM
Aug 8, 2017 12:01PM
Aug 8, 2017 12:00PM Fate Therapeutics Announces Publication of Preclinical Data in Cancer Research and FDA Clearance of Third IND for FATE-NK100
Mar 13, 2017 09:31AM
Sep 26, 2016 09:29AM
Sep 13, 2016 09:26AM
Sep 12, 2016 05:35PM
Jun 20, 2016 09:30AM
Jan 27, 2016 09:29AM
Jan 26, 2016 06:06PM After-Hours Stock Movers 01/26: (FATE) (RPTP) (ETH) Higher; (X) (LCI) (VMW) Lower (more...)
May 21, 2015 09:32AM
May 7, 2015 04:01PM
May 7, 2015 04:01PM
May 6, 2015 01:03PM
May 6, 2015 09:27AM
Mar 3, 2015 07:13AM
May 13, 2014 04:01PM Fate Therapeutics Reports First Quarter 2014 Financial Results

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All